Solux Co. Ltd (290690) - Net Assets

Latest as of March 2026: ₩84.98 Billion KRW ≈ $57.59 Million USD

Based on the latest financial reports, Solux Co. Ltd (290690) has net assets worth ₩84.98 Billion KRW (≈ $57.59 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩154.84 Billion ≈ $104.93 Million USD) and total liabilities (₩69.87 Billion ≈ $47.35 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 290690 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩84.98 Billion
% of Total Assets 54.88%
Annual Growth Rate 29.71%
5-Year Change 89.61%
10-Year Change N/A
Growth Volatility 35.82

Solux Co. Ltd - Net Assets Trend (2018–2025)

This chart illustrates how Solux Co. Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Solux Co. Ltd stock valuation.

Annual Net Assets for Solux Co. Ltd (2018–2025)

The table below shows the annual net assets of Solux Co. Ltd from 2018 to 2025. Also explore Solux Co. Ltd (290690) equity growth momentum to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 ₩90.89 Billion
≈ $61.60 Million
+16.03%
2024-12-31 ₩78.33 Billion
≈ $53.09 Million
+25.49%
2023-12-31 ₩62.42 Billion
≈ $42.30 Million
+44.03%
2022-12-31 ₩43.34 Billion
≈ $29.37 Million
-9.59%
2021-12-31 ₩47.94 Billion
≈ $32.49 Million
+11.46%
2020-12-31 ₩43.01 Billion
≈ $29.15 Million
+111.87%
2019-12-31 ₩20.30 Billion
≈ $13.76 Million
+38.00%
2018-12-31 ₩14.71 Billion
≈ $9.97 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Solux Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 332.5% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components ₩123.80 Billion 136.20%
Total Equity ₩90.89 Billion 100.00%

Solux Co. Ltd Competitors by Market Cap

The table below lists competitors of Solux Co. Ltd ranked by their market capitalization.

Company Market Cap
Forrester Research Inc
NASDAQ:FORR
$131.74 Million
O-TA Precision Industry Co Ltd
TWO:8924
$131.74 Million
ANJI Technology Co. Ltd
TW:6477
$131.82 Million
Graphene Manufacturing Group Ltd
V:GMG
$131.90 Million
VenueG Co. Ltd
KQ:019010
$131.72 Million
FENIX Resources Ltd
AU:FEX
$131.69 Million
NCC AB (publ)
ST:NCC-A
$131.67 Million
Ambra SA
WAR:AMB
$131.67 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Solux Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 78,334,746,340 to 90,894,632,510, a change of 12,559,886,170 (16.0%).
  • Net loss of 7,715,428,230 reduced equity.
  • New share issuances of 809,997,620 increased equity.
  • Other factors increased equity by 19,465,316,780.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income ₩-7.72 Billion -8.49%
Share Issuances ₩810.00 Million +0.89%
Other Changes ₩19.47 Billion +21.42%
Total Change ₩- 16.03%

Book Value vs Market Value Analysis

This analysis compares Solux Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.11x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 1.66x to 2.11x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-12-31 ₩2372.59 ₩3940.00 x
2019-12-31 ₩3274.13 ₩3940.00 x
2020-12-31 ₩5271.78 ₩3940.00 x
2021-12-31 ₩5805.75 ₩3940.00 x
2022-12-31 ₩5248.90 ₩3940.00 x
2023-12-31 ₩2130.56 ₩3940.00 x
2024-12-31 ₩1642.22 ₩3940.00 x
2025-12-31 ₩1864.53 ₩3940.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Solux Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -8.49%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -20.16%
  • • Asset Turnover: 0.27x
  • • Equity Multiplier: 1.56x
  • Recent ROE (-8.49%) is below the historical average (-2.25%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 15.93% 4.31% 1.24x 2.98x ₩872.26 Million
2019 28.54% 8.15% 1.47x 2.38x ₩3.76 Billion
2020 10.34% 7.71% 0.87x 1.55x ₩144.93 Million
2021 8.67% 5.94% 0.95x 1.54x ₩-637.06 Million
2022 -9.99% -7.75% 0.82x 1.58x ₩-8.67 Billion
2023 -10.73% -11.19% 0.37x 2.57x ₩-12.94 Billion
2024 -52.31% -80.83% 0.43x 1.50x ₩-48.81 Billion
2025 -8.49% -20.16% 0.27x 1.56x ₩-16.80 Billion

Industry Comparison

This section compares Solux Co. Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $374,207,764,170
  • Average return on equity (ROE) among peers: -9.63%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Solux Co. Ltd (290690) ₩84.98 Billion 15.93% 0.82x $131.72 Million
ORIENTBIO Inc. (002630) $51.96 Billion -20.94% 0.39x $73.37 Million
Green Cross (005250) $1.88 Trillion -2.88% 0.99x $295.07 Million
Green Cross Holdings Preference Shares (005257) $1.44 Trillion 3.01% 0.78x $2.94 Million
Pharmicell (005690) $82.82 Billion -21.94% 0.22x $470.89 Million
GeneOne Life Science Inc (011000) $98.51 Billion -18.93% 0.39x $32.81 Million
HLB Co. Ltd (028300) $23.02 Billion -12.73% 1.36x $2.88 Billion
Mgenplus Co. Ltd. (032790) $17.38 Billion 0.00% 1.46x $22.01 Million
Daesung Microbiological Labs. Co. Ltd (036480) $37.00 Billion 2.34% 0.69x $15.81 Million
Seoulin Bioscience Co.Ltd (038070) $48.60 Billion 8.38% 0.37x $24.32 Million
Hyundai Bioscience Co. Ltd (048410) $61.57 Billion -32.57% 0.31x $435.56 Million

About Solux Co. Ltd

KQ:290690 Korea Biotechnology
Market Cap
$131.72 Million
₩194.37 Billion KRW
Market Cap Rank
#18228 Global
#805 in Korea
Share Price
₩3940.00
Change (1 day)
-0.51%
52-Week Range
₩2720.00 - ₩6020.00
All Time High
₩34400.00
About

ARIBIO Holdings Inc. manufactures and supplies indoor, outdoor, and special purpose lighting products in South Korea and internationally. The company was formerly known as Solux Co., Ltd. and changed its name to ARIBIO Holdings Inc. in July 2026. ARIBIO Holdings Inc. was founded in 1995 and is headquartered in Gongju-si, South Korea.